{
  "author": "CooterThug_69",
  "the_new_excerpt": "Atossa Therapeutics is a clinical-stage biopharmaceutical company working on\ninnovative medicines and treatments for breast cancer (Endoxifen) and COVID-19.\n\nI'm a nutrition science / biopharma student and was reading pappers about breast\ncancer and found that ATOS had a \" A statistically…",
  "original_created_utc": 1623944134,
  "localize": [
    {
      "locale": "ja",
      "the_new_excerpt": "Atossa Therapeuticsは、乳がんに対する革新的な医薬品と治療法（EndoxifenとCOVID-19）の開発に取り組んでいる臨床段階のバイオ医薬品企業です。\nエンドキシフェンやCOVID-19などの革新的な乳がん治療薬を開発しています。\n\n私は栄養学とバイオファーマを専攻している学生で、乳がんについての論文を読んでいました。\n私は栄養学／バイオファーマの学生ですが、乳がんについての論文を読んでいて、ATOSが「統計的に...」と書いてあるのを見つけました。",
      "title": "Atossa Therapeutics（ATOS）に対する意見"
    },
    {
      "locale": "zh",
      "the_new_excerpt": "Atossa Therapeutics是一家处于临床阶段的生物制药公司，致力于开发治疗乳腺癌（Endoxifen和COVID-19）的创新药物和疗法。\n创新药物和治疗乳腺癌（Endoxifen）和COVID-19。\n\n我是一名营养学/生物制药专业的学生，在阅读有关乳腺癌的论文时，发现ATOS在统计学上有 \"A\"。\n我是一名营养学/生物制药专业的学生，在阅读有关乳腺癌的论文时发现，ATOS有一个 \"A统计学\"。",
      "title": "关于Atossa Therapeutics (ATOS)的观点"
    },
    {
      "locale": "zh-Hant",
      "the_new_excerpt": "Atossa Therapeutics是一家處於臨牀階段的生物製藥公司，致力於開發治療乳腺癌（Endoxifen和COVID-19）的創新藥物和療法。\n創新藥物和治療乳腺癌（Endoxifen）和COVID-19。\n\n我是一名營養學/生物製藥專業的學生，在閱讀有關乳腺癌的論文時，發現ATOS在統計學上有 \"A\"。\n我是一名營養學/生物製藥專業的學生，在閱讀有關乳腺癌的論文時發現，ATOS有一個 \"A統計學\"。",
      "title": "關於Atossa Therapeutics (ATOS)的觀點"
    }
  ],
  "title": "Opinions on Atossa Therapeutics (ATOS)",
  "created_utc": 1623952367,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p>Atossa Therapeutics is a clinical-stage biopharmaceutical company working on innovative medicines and treatments for breast cancer (Endoxifen) and COVID-19.</p>\n\n<p>I&#39;m a nutrition science / biopharma student and was reading pappers about breast cancer and found that ATOS had a &quot; <strong>A statistically significant (p = 0.031) reduction of about 74% in tumor cell proliferation was achieved over an average of 22 days of dosing</strong> &quot; on there phase II <a href=\"https://www.globenewswire.com/en/news-release/2020/05/13/2032759/0/en/Atossa-Therapeutics-Announces-First-Quarter-2020-Financial-Results-and-Provides-Company-Update-on-COVID-19-HOPE-and-Endoxifen-Programs.html\">study</a>.</p>\n\n<p>They also had a <a href=\"https://www.abstractsonline.com/pp8/#!/7946/presentation/2006\">28% increase in progression-free survival</a> (the amount of time during and after treatment that the disease doesn&#39;t progress).</p>\n\n<h1>Financials</h1>\n\n<p>They have <strong>138M in cash</strong> and have <strong>no debt</strong>, they spend <strong>3.51M per quarter</strong>, via Q1 2021 <a href=\"https://atossatherapeutics.com/atossa-therapeutics-announces-first-quarter-2021-financial-results-and-provides-corporate-update/\">report</a>.</p>\n\n<p>&#x200B;</p>\n\n<p>They are also being added to the <a href=\"https://content.ftserussell.com/sites/default/files/russell_3000_index_additions_-_2021.pdf\">Russell 3000 index</a>.</p>\n\n<p>&#x200B;</p>\n\n<p>As a student more or less in the same field of work I really like the upside on this company.</p>\n\n<p>But what is your opinion?</p>\n\n<p>&#x200B;</p>\n\n<p>Full disclosure: 11 shares @ 4.5USD (i know its not much but its honest work for a college student)</p>\n\n<p>&#x200B;</p>\n\n<p>EDIT1: as i finish this post ATOS is <strong>up ~14% on the day</strong>, i gess nobody is sleeping on this stock after all.</p>\n</div><!-- SC_ON -->",
  "score": 146,
  "permalink": "/r/investing/comments/o2043p/opinions_on_atossa_therapeutics_atos/",
  "subreddit": "investing",
  "id": "o2043p",
  "is_self": true,
  "media": null,
  "is_video": false,
  "source_updated_at": 1624009742353
}